We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAM icon
3201
Boston Beer
SAM
$1.86B
$325K ﹤0.01%
1,054
-262
-20% -$84.3K
GRPM icon
3202
Invesco S&P MidCap 400 GARP ETF
GRPM
$503M
$325K ﹤0.01%
3,571
-296
-8% -$25.6K
MCI
3203
Barings Corporate Investors
MCI
$343M
$324K ﹤0.01%
21,775
+97
+0.4% +$1.37K
BHC icon
3204
Bausch Health
BHC
$2.3B
$324K ﹤0.01%
40,546
-7,060
-15% -$52.1K
SBUX icon
3205
PUT
Starbucks
SBUX
$122B
$324K ﹤0.01%
+3,500
New +$363K
IVT icon
3206
InvenTrust Properties
IVT
$2.57B
$323K ﹤0.01%
13,975
-1,082
-7% -$24.4K
RLTY icon
3207
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$260M
$323K ﹤0.01%
23,434
-28,409
-55% -$377K
BHVN icon
3208
Biohaven
BHVN
$2.17B
$322K ﹤0.01%
+13,480
New +$232K
FIDU icon
3209
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
$322K ﹤0.01%
5,666
+1,433
+34% +$75.9K
PMF
3210
DELISTED
PIMCO Municipal Income Fund
PMF
$322K ﹤0.01%
31,338
+10,564
+51% +$106K
PPH icon
3211
VanEck Pharmaceutical ETF
PPH
$990M
$322K ﹤0.01%
4,087
-2,619
-39% -$205K
NUS icon
3212
Nu Skin
NUS
$250M
$321K ﹤0.01%
9,675
-154
-2% -$5.67K
HYT icon
3213
BlackRock Corporate High Yield Fund
HYT
$1.37B
$321K ﹤0.01%
35,986
-961
-3% -$8.32K
GTLB icon
3214
GitLab
GTLB
$6.97B
$321K ﹤0.01%
6,278
-727
-10% -$27K
NUSA icon
3215
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$34.6M
$320K ﹤0.01%
14,035
+4,485
+47% +$103K
GPP
3216
DELISTED
Green Plains Partners LP
GPP
$320K ﹤0.01%
24,765
-3,624
-13% -$46.3K
WOOF icon
3217
Petco
WOOF
$774M
$320K ﹤0.01%
35,931
-475
-1% -$4.37K
FSZ icon
3218
First Trust Switzerland AlphaDEX Fund
FSZ
$37.3M
$320K ﹤0.01%
5,324
+235
+5% +$14.5K
IMGN
3219
DELISTED
Immunogen Inc
IMGN
$319K ﹤0.01%
16,926
-28,482
-63% -$336K
ARTY
3220
iShares Future AI & Tech ETF
ARTY
$3.97B
$319K ﹤0.01%
+9,664
New +$297K
LYTS icon
3221
LSI Industries
LYTS
$916M
$319K ﹤0.01%
25,422
-2,100
-8% -$26.3K
MUST icon
3222
Columbia Multi-Sector Municipal Income ETF
MUST
$599M
$319K ﹤0.01%
15,544
PRN icon
3223
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$446M
$319K ﹤0.01%
3,028
+120
+4% +$11.5K
CIM
3224
Chimera Investment
CIM
$995M
$318K ﹤0.01%
18,358
-14,208
-44% -$226K
JMOM icon
3225
JPMorgan US Momentum Factor ETF
JMOM
$2.63B
$316K ﹤0.01%
+7,450
New +$298K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.